fenta sl 267 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 267 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 267 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 267 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 400 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 400 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 400 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 400 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 533 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 533 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 533 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 533 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 800 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 800 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 800 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 800 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 133 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 133 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.
fenta sl 133 sublingual tablets
rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 133 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.